Published in
American Society of Hematology, Blood, 16(130), p. 1800-1808, 2017
DOI: 10.1182/blood-2017-03-769620
Links
Tools
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Journal article published in 2017 by
Michael Crump,
Sattva S. Neelapu,
Umar Farooq,
Eric Van Den Neste,
John Kuruvilla,
Jason Westin,
Brian K. Link 
,
Annette Hay ,
James R. Cerhan,
Liting Zhu,
Sami Boussetta,
Lei Feng,
Matthew J. Maurer,
Lynn Navale,
Jeff Wiezorek
and other authors.
,
Annette Hay ,
James R. Cerhan,
Liting Zhu,
Sami Boussetta,
Lei Feng,
Matthew J. Maurer,
Lynn Navale,
Jeff Wiezorek
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points SCHOLAR-1 is the first patient-level analysis of outcomes of refractory DLBCL from 2 large randomized trials and 2 academic databases. SCHOLAR-1 demonstrated poor outcomes in patients with refractory DLBCL, supporting a need for more effective therapies for these patients.